Takeda Pharmaceutical (TKPHF) Shares Repurchased (2018 - 2025)
Historic Shares Repurchased for Takeda Pharmaceutical (TKPHF) over the last 8 years, with Q2 2025 value amounting to -$356.6 million.
- Takeda Pharmaceutical's Shares Repurchased fell 284987.87% to -$356.6 million in Q2 2025 from the same period last year, while for Dec 2025 it was -$684.2 million, marking a year-over-year decrease of 555949.32%. This contributed to the annual value of -$340.5 million for FY2025, which is 201084.39% down from last year.
- Takeda Pharmaceutical's Shares Repurchased amounted to -$356.6 million in Q2 2025, which was down 284987.87% from -$327.6 million recorded in Q1 2025.
- Takeda Pharmaceutical's Shares Repurchased's 5-year high stood at -$28342.5 during Q1 2021, with a 5-year trough of -$439.8 million in Q4 2021.
- Its 5-year average for Shares Repurchased is -$177.7 million, with a median of -$208.2 million in 2022.
- As far as peak fluctuations go, Takeda Pharmaceutical's Shares Repurchased crashed by 153185703.83% in 2021, and later skyrocketed by 9184.89% in 2023.
- Takeda Pharmaceutical's Shares Repurchased (Quarter) stood at -$439.8 million in 2021, then surged by 52.66% to -$208.2 million in 2022, then surged by 91.85% to -$17.0 million in 2023, then rose by 28.77% to -$12.1 million in 2024, then plummeted by 2849.88% to -$356.6 million in 2025.
- Its last three reported values are -$356.6 million in Q2 2025, -$327.6 million for Q1 2025, and -$12.1 million during Q2 2024.